SNMMI, others call for Mo-99 supply funding in US
In a letter to the Senate and House
subcommittees on Energy and Water Development, SNMMI President Satoshi
Minoshima, MD, PhD, joined with leaders of the American Society of Nuclear
Cardiology, American College of Cardiology, American College of Radiology,
patient groups, radiopharmaceutical manufacturers and distributors, and medical
imaging companies to urge support of a provision in both the Senate and House
bills that would provide $20 million in additional funding to continue
establishing domestic production of molybdenum-99 (Mo-99), from which
technecium-99m (Tc-99m) is derived.
The letter points out that despite
the American Medical Isotope Production Act of 2012 (AMIPA), a sufficient
domestic supply has not been established. In addition, the global Mo-99
industry has been facing supply challenges, meaning patient access to important
nuclear medicine procedures continues to be at risk.
The signers requested language that
clearly delineates the use of the entire $20 million for NNSA’s medical isotope
program and added the hope that the Department of Energy can be directed to use
maximum flexibility in allowing pre-award funding for those expenses directly
related to projects from the beginning of Fiscal Year 2018.
To read the more please visit:
http://www.snmmi.org/NewsPublications/NewsDetail.aspx?ItemNumber=29590
Source: SNMMI